TCM gets nod to finalize potential acquisition of Edayar Zinc

12 Feb 2019 Evaluate

TCM has received an approval to negotiate, finalize the terms and conditions of the proposed potential acquisition of Edayar Zinc shares within the company and sign on behalf of the Company the final ‘Term Sheet’ for the said potential acquisition and also in all necessary documents.

The Board of the company at their meeting held on February 12, 2019, authorized Joseph Varghese, Managing Director to negotiate, finalize the same.

TCM is engaged in the manufacture of Potassium Chlorate – a vital raw material for the match Industry.

TCM Share Price

52.00 0.94 (1.84%)
04-Feb-2026 10:06 View Price Chart
Peers
Company Name CMP
BASF India 3744.50
Tata Chemicals 717.15
SRF 2921.05
Pidilite Inds. 1469.15
Deepak Nitrite 1628.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×